Lucis

Lucis

Private
Artannes-sur-Indre, Centre-Val de LoireHealthcare & Life Scienceshttps://www.lucis.life

Last Round

Series A

May 26, 2026

Total Funding Raised

$29M

Momentum Score

50 /100

Company Overview

Lucis is a European preventative health-tech platform, formerly known as Zero Health, that is backed by Y Combinator. The company's service transforms standard blood test results into actionable health insights using artificial intelligence and medical expertise. It provides users with personalized health scores, biological age estimates, and tailored recommendations for lifestyle, nutrition, and sleep to help them improve their long-term health. Operating on a subscription model, Lucis partners with a network of labs across Europe, making proactive health monitoring more accessible.

Sector

Healthcare & Life Sciences

Verticals

Healthcare Analytics, Precision Medicine, Subscription Commerce, Medical AI, D2C Brands

Business Model

B2C

Customer Profile

Subscription SaaS, Hardware Sales

AI Layer

Application

Keywords

preventive healthblood test analysishealth subscriptionbiomarker analysisbiological age trackinglongevity techpersonalized healthbiohackingD2C healthdisease preventioncorporate wellnessAI health analysisnutritional supplementscontinuous glucose monitoringCGMmicrobiome testing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Lucis Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Lucis Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series AMay 26, 2026
SeedDec 16, 2025
SeedJun 25, 2025

Key People

Founding team and executive leadership

Baptiste Debever

Co-Founder CTO

Founding Team

Lucis Investors

Notable investors and investment history

InvestorRounds
Kima VenturesSeed
LongGame VenturesSeed
Circle & CoSeed
SingularSeries A
General CatalystSeries A, Seed
Motier VenturesSeed
Y CombinatorSeed, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 26, 2026

    $20M round led by Singular.

  • Mar 4, 2026

    Launched a digital preventive health pathway in France with Livi.

Lucis Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Lucis Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Lucis's valuation, stock price, and market status.

Firmographic Details

HeadquartersArtannes-sur-Indre, Centre-Val de Loire
Employee Range28
Year Founded2025
Last FundingMay 26, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.